Syra Health Corp. Reports 22.3% Revenue Growth and Net Income of $240,979 in Q1 2026

Syra Health Corp. reported a significant increase in financial performance for the first quarter of 2026, with net revenues reaching $2.27 million, up 22.3% from $1.86 million in the same period last year. The company achieved a gross profit of $971,255, compared to $589,156 in the prior year, reflecting a gross margin improvement. Operating expenses decreased to $780,272 from $1.06 million, leading to an operating income of $190,983, a turnaround from an operating loss of $473,334 in the first quarter of 2025. The net income for the quarter was $240,979, translating to earnings per share of $0.02, compared to a loss of $0.04 per share in the previous year.

The company’s balance sheet showed total assets of $3.94 million as of March 31, 2026, a substantial increase from $2.77 million at the end of 2025. Current assets rose to $3.93 million, primarily driven by an increase in cash and cash equivalents, which reached $2.92 million, up from $1.61 million. Current liabilities also increased significantly to $1.58 million from $674,739, largely due to a rise in deferred revenue, which jumped to $750,524 from $16,611. This increase in deferred revenue indicates a growing demand for Syra's services.

Strategically, Syra Health has focused on expanding its service offerings and enhancing operational efficiency. The company continues to provide workforce staffing solutions and health education services primarily to state and federal health authorities. The revenue breakdown for the quarter showed that the Population Health segment generated $1.76 million, a notable increase from $1.20 million in the previous year, while Healthcare Workforce revenues decreased to $513,002 from $655,217. This shift suggests a strategic pivot towards more profitable service lines.

Operationally, Syra Health reported a customer base that is increasingly reliant on its services, with significant contracts from the Indiana Family and Social Services Administration (FSSA) contributing to approximately 20% of revenues in the latest quarter. The company has also seen improvements in cash flow, with net cash provided by operating activities amounting to $1.36 million, compared to $158,231 in the first quarter of 2025. The company’s employee headcount remains stable, supporting its operational capabilities as it navigates growth opportunities.

Looking ahead, Syra Health Corp. acknowledges the need for additional capital to sustain its operations and support growth initiatives. The company has raised $1.45 million from convertible notes and approximately $5.33 million from its recent IPO, which it plans to use to enhance its service offerings and expand its market presence. However, management has expressed caution regarding future revenue projections, emphasizing the inherent risks and uncertainties in the healthcare sector. The company remains committed to pursuing strategic partnerships and operational efficiencies to bolster its financial position and market share.